Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR750 in Trigeminal Neuralgia
NCT06571448Phase 2Completed
- Sponsor
- Shanghai SIMRD Biotechnology Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SR750 in trigeminal neuralgia (TN), sponsored by Shanghai SIMRD Biotechnology Co., Ltd.. Started Sep 2024; status: completed.
02
Drugs
SR750
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT06571448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06571448.